West Tennessee Eye Care, P.C.

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Clinical Efficacy of Two Topical Dry Eye Drops for Central Corneal Stain Clearing Over 90 Days

First Posted Date
2019-11-21
Last Posted Date
2022-10-20
Lead Sponsor
Toyos Clinic
Target Recruit Count
100
Registration Number
NCT04172961
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Toyos Clinic, Nashville, Tennessee, United States

Manuka Eye Droops for Treatment of Allergy

Phase 4
Withdrawn
Conditions
Allergic Conjunctivitis
Interventions
Drug: Manuka honey
First Posted Date
2019-03-05
Last Posted Date
2020-10-09
Lead Sponsor
Toyos Clinic
Registration Number
NCT03862053
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Toyos Clinic, Nashville, Tennessee, United States

Efficacy and Safety of Meibomian Gland Dysfunction and Dry Eye With an LED Blue Treatment Device

Not Applicable
Withdrawn
Conditions
Meibomian Gland Dysfunction
Interventions
Device: 2-3 Joule LED blue light device
First Posted Date
2018-12-27
Last Posted Date
2020-10-08
Lead Sponsor
Toyos Clinic
Registration Number
NCT03788486
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Toyos Clinic, Nashville, Tennessee, United States

Intense Pulse Light Treatment With Meibomian Gland Expression of the Upper Eyelids in Dry Eye Disease

Not Applicable
Completed
Conditions
Dry Eye
Interventions
Device: intense pulsed light
First Posted Date
2018-09-05
Last Posted Date
2019-02-12
Lead Sponsor
Toyos Clinic
Target Recruit Count
19
Registration Number
NCT03658811
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Toyos Clinic, Nashville, Tennessee, United States

Clinical Comparison of Length of Cataract Procedures With Zeiss Lumera Versus Older Zeiss Microscope

Completed
Conditions
Cataract
First Posted Date
2017-10-02
Last Posted Date
2021-04-22
Lead Sponsor
Toyos Clinic
Target Recruit Count
50
Registration Number
NCT03298841
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Toyos Clinic, Nashville, Tennessee, United States

Clinical Efficacy of H.P. Acthar Gel 80 U/ml to Improve the Signs and Symptoms in Subjects With Dry Eye Disease

First Posted Date
2017-09-19
Last Posted Date
2021-01-28
Lead Sponsor
Toyos Clinic
Target Recruit Count
19
Registration Number
NCT03287635
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Toyos Clinic, Nashville, Tennessee, United States

Single Center, Prospective, Randomized, Controlled, Non-significant Risk

Withdrawn
Conditions
Dry Eye
First Posted Date
2017-09-18
Last Posted Date
2023-12-12
Lead Sponsor
Toyos Clinic
Registration Number
NCT03286166
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Toyos Clinic, Nashville, Tennessee, United States

Clinical Outcomes and Evaluation of Lotemax 0.5% in Treatment of Ocular Inflammation Associated With Cataract Surgery

Completed
Conditions
Pseudophakia
Inflammation
First Posted Date
2011-04-29
Last Posted Date
2018-10-22
Lead Sponsor
Toyos Clinic
Target Recruit Count
49
Registration Number
NCT01344226
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Discover Vision Centers, Independence, Missouri, United States

Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1%

Phase 4
Completed
Conditions
Inflammation
Pseudophakia
Interventions
Drug: Bromfenac
Drug: Nepafenac
First Posted Date
2011-03-08
Last Posted Date
2020-10-28
Lead Sponsor
Toyos Clinic
Target Recruit Count
23
Registration Number
NCT01310127
ยฉ Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy